CLINICAL_TRIALS
trial_result
· 2022-09-28
Clinical Trial Update: INDV-2000 First in Human [Phase 1]
Summary
INDV-2000 from Indivior completed its first-in-human Phase 1 trial for opioid use disorder. Results from the study have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Indivior Inc. | Conditions: Opioid Dependence | Phase 1 | Status: COMPLETED | Results posted: 2022-09-28